UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000016407
Receipt number R000019056
Scientific Title Unusual sensation and sensorimotor functions in Autism spectrum disorders Study1:Decoding eye movement information for the understanding of its psychosocial functions
Date of disclosure of the study information 2015/02/02
Last modified on 2017/08/15 08:16:52

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Unusual sensation and sensorimotor functions in Autism spectrum disorders Study1:Decoding eye movement information for the understanding of its psychosocial functions

Acronym

Unusual sensation and sensorimotor functions in Autism spectrum disorders Study1: Eye movements

Scientific Title

Unusual sensation and sensorimotor functions in Autism spectrum disorders Study1:Decoding eye movement information for the understanding of its psychosocial functions

Scientific Title:Acronym

Unusual sensation and sensorimotor functions in Autism spectrum disorders Study1: Eye movements

Region

Japan


Condition

Condition

Autism spectrum disorder (ASD)

Classification by specialty

Psychiatry Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of this research is to explore the underlying mechanisms and psychosocial influence of eye movements specific to ASD.

Basic objectives2

Others

Basic objectives -Others

We also investigate unusual perceptual functions in connection with ASD specific eye movement patterns.

Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Behavioral data (eye movement, reaction time, error rate) and psychological tests

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Diagnosis

Type of intervention

Other

Interventions/Control_1

Adults with ASD

Interventions/Control_2

Adults without ASD

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

40 years-old >=

Gender

Male and Female

Key inclusion criteria

(a) Adults with ASD
Adults who were diagnosed according to the Diagnostic and Statistical Manual of Mental Disorder, Fourth Edition, Text Revision (DSM-IV-TR) criteria for autism spectrum disorder

(a) Adults without ASD
Controls will be selected to match the ASD group as closely as possible on chronological age, gender, and full intelligence quotient (FIQ).

We explain the purpose of the study to each participant beforehand, and ask him/her to participate in our experiments only when the person understands the purpose of our research and is willing to take part in.

Key exclusion criteria

Subjects who are judged as unsuitable for participation in this study by their primary doctor (patients only)

Target sample size

40


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Aya Shirama

Organization

Nippon Telegraph and Telephone Corporation

Division name

NTT Communication Science Laboratories

Zip code


Address

3-1, Morinosato Wakamiya, Atsugi-shi, Kanagawa

TEL

046-240-3668

Email

shirama.aya@lab.ntt.co.jp


Public contact

Name of contact person

1st name
Middle name
Last name Aya Shirama

Organization

Nippon Telegraph and Telephone Corporation

Division name

NTT Communication Science Laboratories

Zip code


Address

3-1, Morinosato Wakamiya, Atsugi-shi, Kanagawa

TEL

046-240-3668

Homepage URL


Email

shirama.aya@lab.ntt.co.jp


Sponsor or person

Institute

Nippon Telegraph and Telephone Corporation, NTT Communication Science Laboratories

Institute

Department

Personal name



Funding Source

Organization

Nippon Telegraph and Telephone Corporation, NTT Communication Science Laboratories

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

昭和大学発達障害医療研究所


Other administrative information

Date of disclosure of the study information

2015 Year 02 Month 02 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2014 Year 12 Month 24 Day

Date of IRB


Anticipated trial start date

2015 Year 02 Month 02 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 02 Month 01 Day

Last modified on

2017 Year 08 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019056


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name